|本期目录/Table of Contents|

[1]张庆明,徐云燕,顾宁宁,等.灵芝菌-玄七通痹胶囊药渣双向发酵工艺的研究[J].医学研究与战创伤救治(原医学研究生学报),2016,18(06):585-590.[doi:10.3969/j.issn.1672-271X.2016.06.008]
 ZHANG Qing-ming,XU Yun-yan,GU Ning-ning,et al.Study on the bi-directional fermentation process of Ganoderma lucidum and xuanqi Tongbi residue[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(06):585-590.[doi:10.3969/j.issn.1672-271X.2016.06.008]
点击复制

灵芝菌-玄七通痹胶囊药渣双向发酵工艺的研究()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第18卷
期数:
2016年06期
页码:
585-590
栏目:
出版日期:
2016-11-20

文章信息/Info

Title:
Study on the bi-directional fermentation process of Ganoderma lucidum and xuanqi Tongbi residue
作者:
张庆明1徐云燕1顾宁宁2张兴德2
1. 210002江苏南京,南京军区南京总医院制剂科;2. 210023江苏南京,南京中医药大学药学院
Author(s):
ZHANG Qing-ming1 XU Yun-yan1 GU Ning-ning2 ZHANG Xing-de2.
1. Department of Preparations,Nanjing General Hospital of Nanjing Military Command, Nanjing,Jiangsu 210002,China; 2. College of Pharmacy,Nanjing Universiy of Chinese Medicine, Nanjing, Jiangsu 210023,China
关键词:
灵芝菌玄七通痹胶囊药渣双向发酵多糖灵芝酸
Keywords:
Ganoderma lucidum xuanqi Tongbi residue bi-directional fermentation polysaccharide ganoderic acid
分类号:
Q815
DOI:
10.3969/j.issn.1672-271X.2016.06.008
文献标志码:
A
摘要:
目的 优化灵芝菌-玄七通痹胶囊药渣双向发酵工艺,初步探讨其主要活性组分的物质差异。方法 以多糖、灵芝酸和皂苷作为检测指标,考察药渣浓度、固液比、药渣粒径等因素对灵芝菌发酵 玄七通痹胶囊药渣的影响,并利用高效液相色谱(HPLC)技术分析添加药渣发酵后主要活性组分的物质差异。结果 以多糖为目标产物,最佳的药渣添加量25%,固液比1∶1.5,药渣粒径60目过筛,发酵 时间25 d;以灵芝酸为目标产物,最佳的药渣添加量40%,固液比1∶1.8,药渣粒径60目过筛,发酵时间30 d。并且添加药渣发酵后,在多糖组分和灵芝酸组分中都产生了新的物质。结论 本研究不仅将 为解决中药渣直接排向环境造成的污染等问题提供参考,而且还为实现中药渣再利用、新药及功能饲料添加剂的开发提供依据。
Abstract:
Objective To optimize bi-directional fermentation process of Ganoderma lucidum and xuanqi Tongbi residue and discover new substances from main active components. Methods With the contents of polysaccharide, ganoderic acid and saponin as detection index, the effects of fermentative parameters, such as drug residue concentration, solid- liquid ratio, particle size of residue on the yield of active substrates by Ganoderma lucidum were studied. Then the new substances in main active components produced by bi- directional fermentation were analyzed using HPLC methods. Results Taking polysaccharide as the target product, the optimal fermentation condition were as follows: drug residue concentration was 25%, the ratio of solid to liquid was 1∶1.5, the particle size of residue was 60 mesh and the time was 25 d. After fermentation, the new substances both in polysaccharide component and ganoderic acid component were produced. Conclusion This study will not only provide reference for solving the pollution problems caused by the direct discharge of traditional Chinese medicine residues, but also provide the basis for the reuse of traditional Chinese medicine residues and the development of new drugs and functional feed additives.

参考文献/References:

[1]王浩,严嘉敏,罗佳. 中药药渣深入利用的研究进展[J]. 中药与临床,2015,6(3):62-65.
[2]刘文伟,刘玉璇,赵宇,等. 中药渣综合利用研究进展[J]. 药学研究,2013,32(1):49-50.
[3]潘文华,邓乔丹,冯毅翀,等. 中药渣综合利用的可行性分析[J]. 时珍国医国药,2011,22(8):2026-2027.
[4]Liu L, Kurashiki K, Fukuta A, et al. Quantitative determination of the representative triterpenoids in the extracts of Ganoderma lucidum with different growth stages using high-performance liquid chromatography for evaluation of their 5α-reductase inhibitory properties[J].Food Chem, 2012,133(3):1034-1038.
[5]丁妍,周向毅,崔莉,等. 灵芝多糖对辐射损伤小鼠的防护作用[J]. 医学研究生学报,2014, 27(11):1152-1155.
[6]庄毅,潘扬,谢小梅,等. 药用真菌“双向发酵”的起源、发展及其优势与潜力[J]. 中国食用菌,2007,26(2):3-6.
[7]陈合,赵燕,陈明,等. 利用中药渣培养灵芝菌及生物活性成分的研究[J]. 食品工业科技,2006,27(10):58-63.
[8]庄毅,洪净. 药用真菌双向固体发酵工程与中成药药渣开发[J]. 中国中药杂志,2006,31(22):8191-8192.
[9]陈玉胜,阮鸣,张李阳,等. “芝芪菌质”发酵配方的筛选及主要有效成分的含量测定[J]. 安徽农业科学,2008,36(4):1310-1311,1313.
[10]于淼,原源. HPLC测定益心酮片中四种黄酮类成分的含量法[J]. 东南国防医药,2015,17(2):157-159,165.
[11]王建芳,徐春,徐萌萌,等. 利用香菇发酵中药废渣提高利用价值的研究[J]. 四川大学学报,2007,44(12):451-454.
[12]郑浩然,杨海龙. 铁皮石斛对灵芝多糖深层发酵的影响[J]. 安徽农业科学,2016, 44(19):141-142.

相似文献/References:

[1]张庆明,徐云燕,陈美惠,等.灵芝菌固体发酵感冒清热颗粒药渣的主要活性物质变化研究[J].医学研究与战创伤救治(原医学研究生学报),2019,21(6):616.[doi:10.3969/j.issn.1672-271X.2019.06.014]
 ZHANG Qing-ming,XU Yun-yan,CHEN Mei-hui,et al.Study on the changes of main active substances in Ganoderma lucidum solid fermentation Ganmao Qingre Granule drug residue[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(06):616.[doi:10.3969/j.issn.1672-271X.2019.06.014]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-11-20